News
All our News
2024-11-15
New research report published
“Research that works – curing childhood cancer, alleviating long-term effects”: This is the title of the new research report published by the Research Institute at the Children's Cancer Center Hamburg.
2024-10-24
A warm welcome! Dr. Marius Mader starts new working group at the Research Institute Children's Cancer Center Hamburg
What role do immune cells play in childhood brain tumors? Dr. Marius Mader and his research group at the Research Institute Children's Cancer Center Hamburg will address this question starting October.
2024-09-26
Award for Prof. Ulrich Schüller: new medulloblastoma type discovered
At this year's annual conference of the German Society for Neuropathology and Neuroanatomy (DGNN), Prof. Ulrich Schüller won first prize for his poster on discovering a new type of medulloblastoma.
2024-09-26
Werner Rosenthal Prize for promising therapeutic approach for malignant brain tumours
Dr Catena Kresbach has been awarded the Werner Rosenthal Prize by the German Society for Neuropathology and Neuroanatomy (DGNN) for publishing an innovative treatment method for children with malignant brain tumour medulloblastoma.
2024-07-15
Research Institute Children's Cancer Center Hamburg receives funding from “Fight Kids Cancer”
The European "Fight Kids Cancer" (FKC) program has selected two projects involving researchers from the Research Institute Children's Cancer Center Hamburg for its 2024 funding round. They will receive funding of approximately 3 million euros. The research projects focus on childhood cancers that are particularly difficult to treat.
2024-02-15
Hattrick against brain and spinal cord tumors in children
They are rare and occur in both the brain and spinal cord of children: Tumors called ependymomas. Three scientists from Prof. Ulrich Schüller's research group at the Research Institute "Kinderkrebs-Zentrum Hamburg" have now achieved groundbreaking results that will make it possible to better diagnose and treat these tumors in the future.
2023-11-14
New approaches in the treatment of childhood brain tumors: Researchers at the Children's Cancer Center Hamburg publish an innovative therapeutic approach
Medulloblastoma is the most common malignant brain tumor in children. Treating a medulloblastoma requires very intensive multimodal therapy, which includes surgical resection, intensive chemotherapy and, in some cases, radiotherapy.
2023-09-10
Emma & Christof Stoll bridging seminar
Scientific exchange in the field of pediatric oncology With the bridging seminar financed by the Stoll VITA Foundation, we bring clinicians and scientists together and enable professional exchange with internal and external experts. We are looking forward to the next bridge seminar on August 20 at 4:30 p.m. with Dr. med. Dr. rer. nat. Roland […]
2023-08-26
New approaches in the diagnosis of childhood brain tumors
Brain tumors are one of the major challenges in pediatric oncology. They are characterized by an enormous biological heterogeneity and are at the top of cancer-related mortality rates in children due to their often aggressive course.
2023-06-08
World Brain Cancer Day 2023. Still so much to do
Prof. Dr. Ulrich Schüller is a senior physician at the Institute of Neuropathology, responsible for the diagnosis of pediatric brain tumors and for molecular neuropathology. The focus of his research at the Research Institute Children's Cancer Center Hamburg is the neurobiology of pediatric brain tumors and pediatric neuro-oncology.
2023-05-02
Please apply now! Juli-Harnack-grant 2023
In 2023, the Fördergemeinschaft Kinderkrebs-Zentrum Hamburg e.V., together with the Clinic for Pediatric Hematology and Oncology (PHO), will continue to offer four grants (1000 EUR / month each) for medical students, who are interested in a dissertation in the field of pediatric cancer research (1 year / full-time / start: October 1, 2023). Current topics […]
2023-02-21
DG-GT-Price for Innovative LEC-CAR therapy approach
The German Society for Gene Therapy (DG-GT) is an association of physicians, natural scientists and other professional groups who deal with questions of experimental and clinical gene therapy. Every quarter, the society awards high-ranking gene therapy publications with the DG-GT "Paper of the Quarter" price.
